The funding financial institution’s credit score facility will lengthen IO Biotech’s liquidity till the second quarter of 2026, says CFO.
发布者:BY WILLIAM RONFELDT KRISTENSEN,转转请注明出处:https://robotalks.cn/eib-lends-nearly-eur-60m-to-cancer-vaccine-developer-io-biotech/